CRISPR and Cas Genes Market Forecast 2024–2034
Market Overview The CRISPR and Cas Genes Market is entering a decisive growth phase, driven by accelerating adoption of genome-editing technologies across medicine, agriculture, and biotechnology. The market is anticipated to expand from USD 4.28 billion in 2024 to USD 24.6 billion by 2034 , advancing at a robust CAGR of approximately 19.1% . At its core, this market encompasses tools, reagents, platforms, and services built around CRISPR-Cas systems, enabling highly precise DNA modifications. What makes CRISPR transformative is its accessibility and accuracy compared to legacy gene-editing approaches. Today, it supports breakthroughs in personalized medicine, rare disease research, oncology pipelines, and crop resilience programs. Therapeutic applications currently lead adoption, while agriculture is emerging rapidly as producers deploy CRISPR to enhance yield, pest resistance, and climate tolerance. North America remains the dominant region due to deep R&D investment and f...